Atlas Trials

A Phase I/II Study of Diffuse Large B-cell Lymphoma

Clinical trial NCT04856137 · NOT_YET_RECRUITING

Trial details

NCT number
NCT04856137
Sponsor
National Health Research Institutes, Taiwan
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Refractory Diffuse Large B-cell Lymphoma
Start date
2021-05-01
Primary completion
2023-12-31
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.